Log In
BCIQ
Print this Print this
 

EXC 001, PF-06473871, PF-6473871

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense oligonucleotide targeting connective tissue growth factor (CTGF)
Molecular Target Connective tissue growth factor (CTGF)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationScars / wrinkles
Indication DetailsTreat local fibrosis; Treat scarring in patients undergoing abdominoplasty; Treat scars resulting from prior breast surgery
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/05/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today